Oncoplastic Surgery Outcomes Database for Breast Cancer
This study is observing outcomes for women with breast cancer who undergo Oncoplastic Breast Surgery. This surgery combines removing the cancer with reshaping the breast, sometimes including surgery on the other breast for symmetry. Researchers are looking at how successful the surgery is by measuring cancer stage, how satisfied patients are up to one year after surgery, and if the cancer returns for up to 20 years. You may be able to join if you are a biological female, 18 years or older, and need breast cancer surgery with or without reconstruction at Tufts Medicine. The current recruitment status is unclear.
- Study design
- This is an observational study with a planned enrollment of 1500 participants. It involves reviewing past and future patient records.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for up to 20 years after surgery to monitor for cancer recurrence.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Oncoplastic Surgery Outcomes Database
At a glance
Conditions
Where it's being run
2 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Cancer StageFrom enrollment to up to 1 month after surgery.
The TNM system of cancer classification determines the stage of cancer based on type of cancer, size of cancer, lymph node status, presence of metastasis
- Patient SatisfactionFrom enrollment to 1 year after surgery.
Measured using validated surveys pre-operative and post-operative (2 week, 6 month, 1 year).
- Cancer RecurrenceFrom enrollment to 20 years after surgery
Recurrence of cancer following surgery and adjuvant therapy